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COVID-19 is a severe respiratory disorder caused by the SARS COV-2 virus that involves limited innate immunity. 
Numerous publications have suggested that plants/minerals used in the traditional system of Ayurveda, has revealed much 
about the biology of COVID-19. One theory is that combination of anti viral, anti inflammatory, agents activating immune 
cells, herbs and metals may be helpful for severe acute respiratory syndrome coronavirus infection. Anti-viral drugs used for 
COVID-19 are those which block RNA synthesis and virus invasion, and bind to receptor proteins on the surface of cells, 
cell cycle protein, and physiological and pathological processes inhibitor. Anti-inflammatory drugs used for COVID-19 are 
those which controls transcription of DNA, cytokine production, break down the basement membrane, regulate outer 
mitochondrial membrane permeability, controlling the host cell life, stimulates activated B-cell and T-cell proliferation, 
virus dissemination, a slowdown of cell metabolism or secretion of cytokines. Drugs which is having role in the innate 
immunity, inhibits ROS, enhances cell lifespan, activates macrophages, physiological effects on cells activates the Lung 
resident immune cells. The focus of this review is to elucidate the Ayurvedic pharmacological properties with their 
therapeutic targets. 
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According to the World Health Organization (WHO), 
viral diseases continue to emerge and represent a 
serious issue to public health. Recently, the world is 
suffering from an epidemic of cases with unexplained 
low respiratory infection caused due to novel 
coronavirus. Severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) has caused coronavirus 
disease 2019 (COVID-19). It began in Wuhan, China, 
in December 2019 and subsequently spread 
worldwide. The first case of the COVID-19 pandemic 
in India was reported on 30
th
 January 2020. WHO 
declared the outbreak as a Public Health Emergency 
of International Concern and again on 11
th
 March 
2020, declared as Pandemic, with more than 57 
million reported casesin over 188 countries resulting 
in more than 357688 deaths across the globe
1
. The 
infection rate of COVID-19 in India is significantly 
low (1.7) in comparison to the worst affected 
countries. As of May 30 2020, the Ministry of Health 
and Family Welfare has confirmed a total of 168791 
cases, 82369 recoveries (including 1 migration) and 
4971 deaths in the country
2
. 
WHO clinical management guidelines clearly state 
that there is no current evidence to recommend any 
specific treatment for COVID-19 positive patients
3
. 
The guidance regarding the role of supportive care 




SARS-CoV: Severe acute respiratory syndrome coronavirus; 
COVID-19: coronavirus disease 2019; SARS-CoV-2: SARS 
coronavirus-2; Nsps: Nonstructural proteins; PLpro: Papain-like 
proteinase; RdRp: RNA-dependent RNA polymerase; 3CLpro: 
3CL protease inhibitor; IL-1β :Interleukin-1 family; BCL2: B-
cell lymphoma 2; Bfl-1/A1: human homolog of the murine A1, 
EGR-1: Early growth response protein 1; TYK: Non-receptor 
tyrosine-protein kinase; COX: Cyclooxygenase; TNF: Tumor 
necrosis factor; CYP7A1: Cholesterol 7 alpha-hydroxylase; JAK: 
Janus kinase; MMP: Matrix metalloprotease; NF-κB: Nuclear 
factor-kappa B; STAT: Signal transducer and activator of 
transcription; ACE2: Angiotensin-converting enzyme-2; RNA: 
Ribose nucleic acid; C3 or C5: Complement component 3 & 5; 
p38MAPK: P38 mitogen-activated protein kinases; AhR: Aryl 
hydrocarbon receptor; Th1: Type 1 T helper; SOD: Superoxide 
dismutase; CAT: catalase; GPX: Glutathione peroxidase; LPS: 
Lipopolysaccharides; MPO: Myeloperoxidase; AS2O3: Arsenic 
trioxide , ROS: Reactive oxygen species.




symptomatic treatment for the mild disease to 
evidence-based management for acute respiratory 
distress syndrome (ARDS) and early recognition and 
treatment of bacterial infections and sepsis in 
critically ill patients has been emphasized. Although 
no system of medicine has any evidence-based 
treatment for COVID-19 so far, clinical interventions 
are being done worldwide. 
At present, the drug repurposing strategy
4
 is being 
tried across the globe on investigational drugs that are 
outside the scope of the COVID-19. A similar 
strategy is required to be implemented by the 
traditional systems of medicine, including the 
Ayurveda system of medicine which is practiced in 
India more than 5000 years ago. The main objective 
of the Ayurveda system of medicine is to achieve 
optimal health and well-being through a 
comprehensive approach that addresses mind, body, 
behavior, and environment. It is based on two aspects of 
treatment i.e., to maintain the wellness of a healthy 
person and to treat a patient inflicted with a disease
5
. 
Thus, in the present context, for providing preventive, 
supportive and rehabilitative care to COVID-19 patients, 
the Ayurveda system of medicine may be an absolute 
answer. In China too, from where the disease originated 
and spread across the globe, the evidence of the role 
played by Traditional Chinese Medicine (TCM) cannot 
be overlooked
6
. In India, many of the states are using 
Ayurvedic intervention in their treatment protocol as a 
standalone treatment and encouraging results are 
coming
7
. Although high quality scientific evidence  
are lacking, some immunomodulator Ayurvedic  
herbs are being evaluated by multicentric clinical on 
asymptomatic cases of COVID-19 disease. Ministry of 
AYUSH, Government of India has also invited  
research proposals for clinical trials on AYUSH 
interventions for COVID -19 disease and very soon 
such trials will begin. 
The preclinical report suggests the anti-viral, anti-
inflammatory, activation of immune cells and 
antitoxic therapeutic targets may be beneficial in viral 
infections
8
. Based on targets, anti-coronavirus 
therapies may be divided into four categories: (i) anti-
viral therapies, (ii) immune system boosting therapies, 
(iii) anti-inflammatory therapies and (iv) therapies 
with antitoxic effects. The anti-viral therapies, itself 
include preventing the synthesis of viral RNA through 
acting on the genetic material of the virus, inhibiting 
virus replication through acting on critical enzymes of 
the virus, and blocking the virus binding to human 
cell receptors or inhibiting the virus‘s self-assembly 
process through acting on some structural proteins
9
. 
The therapies acting on the human immune system or 
human cells
10
 cause activation of immune cells. Anti-
inflammatory therapeutic targets control transcription 
of DNA, cytokine production, break down the 
basement membrane, regulate outer mitochondrial 
membrane permeability, controlling the host cell life, 
stimulates activated B-cell and T-cell proliferation, 
virus dissemination, a slowdown of cell metabolism 
or secretion of cytokines
11
. Due to the over-exuberant 
of the inflammatory response, one could inhibit 
inflammation by different pathways and thereby may 
inhibit the viral infection of cells. One more therapy 
known as neutralizing antibodies therapy, which 
could prevent the attachment of the virus to its 
receptors on targeted cells by reversing toxic modes 
induced by virus toxins
12
 may also be applied. Many 
scientific studies have revealed that the herbs or 
metals/minerals used in Ayurvedic system of 
medicine either alone or in combination, have anti-
viral, anti-inflammatory, anti-toxic and immune 
boosting potential
13
. In this article, an attempt has 
been made to compile all possible target-based roles 
of different herbs and mineral used in Ayurveda. 
These herbs may be useful in prophylaxis, disease 
state and during the convalescence period, based on 
their use in traditional practices for similar clinical 
conditions. Pathophysiology of SARS-COV-2 
infection, over load on the immune system, 
progression of the disease, therapeutic targets and 
treatment protocol are also highlighted.  
 
Methodology 
The literature available in Ayurveda fundamental 
textbooks, technical reports, and online scientific 
databases such as Pubmed, Science Direct, Scopus, 
Lancet, and Springer for the most recent information 
regarding the Pandemic were searched. The search 
words used were ‗SARS-CoV-2‘, ‗COVID-19‘, 
‗causes‘, ‗types‘, ‗pathogenesis‘, ‗associated risks‘, 
‗diagnosis‘, ‗targets‘, ‗treatments. For scientific 
evidence regarding Ayurveda drugs prescribed during 
epidemics, we searched Google scholar search 
engines. For this search, we focused on Ayurveda 
herbs, nano Bhasmas to understand their role in 
therapeutic targets for antiviral therapy', ‗therapeutic 
targets for anti-inflammatory', ‗therapeutic targets for 
activation of immune cells‘. This search was 
commenced during January 2020 to June 2020. 
Searches were limited to the English language. Biased 
reviews, unpublished records without results were 




excluded. Plant names were validated by ―The Plant 
List‖ (www.theplantlist.org). 
 
Coronavirus disease 2019 (COVID-19) 
 
Structure of Coronavirus 
The Coronavirus are large, roughly spherical, 
particles with bulbous surface projections
14
. The 
envelope of the virus consists of a lipid bilayer in 
which the membrane (M), envelope (E) and spike (S) 
structural proteins are attached. The S protein 
mediates the receptor binding and membrane fusion 
between the virus and the host cell. The E and M 
protein forms the viral envelope and maintains its 
structure. The envelope contains nucleocapsid that is 
bound to the positive-sense single-stranded RNA 
genome. The lipid bilayer envelope, membrane 
proteins and nucleocapsid protect the virus when it is 
outside the host cell. 
 
Mechanism of invasion 
The life cycle of the virus with the host consists of 
attachment, penetration, biosynthesis, maturation, and 
release Virus binds to host receptors (attachment) and 
enters into the host cells (penetration). Viral RNA 
enters the nucleus for replication. Viral mRNA is used 
to make viral proteins (biosynthesis). Then, new viral 
particles are made (maturation) and released.  
The spike for SARS-CoV-2 bound to ACE2 
undergoes protease cleavage at S1/S2 cleavage site
15
 
which is also subjected to cleavage by other proteases 
TMPRSS2
24,25
. In the host cells, the virus likely to 
destroy ACE2 present in the lung epithelial cells, 
dendritic cells and macrophages. T cell responses are 
initiated by antigen presentation via dendrites and 
macrophages. SARS-CoV-2 virus also binds to 
dendritic-cell specific intercellular adhesion 
molecule-3-grabbing nonintegrin (DC-SIGN) and 
DC-SIGN-related protein (DC-SIGNR, L-SIGN) in 
addition to ACE2. It increases the concentration of 
pro-inflammatory cytokines including interleukin 
(IL)-6, IL-10, granulocyte-colony stimulating factor 
(G-CSF), monocyte chemo attractant protein 1 
(MCP1), macrophage inflammatory protein (MIP) 1α 
and tumor necrosis factor (TNF)-α. Exhaustion of T 
cells occurs due to higher expression of CD4+, CD8+, 
CD69, CD38, and CD44. Exhaustion of T cells leads 
to the progression of the disease. 
 
Targeted therapy 




present in herbs and nano-metals used in the 
Ayurveda system; work on a multi-targeted action 
principle
17
. The potential of combination therapy is 
very efficacious because of its low plasma protein 
binding
18
. A combination of several herbs and or 
nano-metals in particular ratio, gives a better 
therapeutic effect, through their Amapachana 
(balancing of Dosha, a kindling of dhatu, 
maintenance of homeostasis), targeting various 
antiviral, anti-inflammatory, immune target 
mediators. Photographs of different plants used 
antiviral activities, anti-inflammatory activities, 
immune cells potentiating activity, and nano minerals 
for COVID-19 are shown in Figure 1. The anti viral, 
anti inflammatory and immune cells activation 
properties of Ayurvedic herbs during SARS-CoV-2 
infection are provided in Figure 2, 3 and 4. The action 
and molecular targets of herbs & metals for their 
possible anti-viral, anti-inflammatory and immune 
cells activation activity in COVID-19 are presented in 
Table 1, 2, 3 and 4. 
 
Discussion 
Targeted therapy is supposed to be most parallel to 
the Ayurvedic treatment approach to Infection. It is 
clearly said that the mechanism of action of Ayurveda 
drugs depends upon the homeostasis of dosha dhatu 
& malas is called as healthy status & disbalance is 
manifested into disease state wherein Agni & external 
factors play a keyrole
19
 Vata, Pitta & Kapha are 
present in every cell of the body. The various organs 
of the body are the aggregates of paramanus, the 
biological cell of an organism, of particular nature. 
The cell/paramanu is responsible for the pysical and 
psychological life activities of that particular 
organism. Since Vata, Pitta, Kapha, are responsible 
for all activities it is logical & scientific to infer that 
three dhatus reside in a cell/paramanu. Therefore, 
biological cell serves as a site for the three dosas.  
This concept is unique to Ayurveda. However, a 
parallel exists in modern science in the form of 
targeted therapy where target emphasis is giving on 
structural proteins abnormality, mRNA genome code 
abnormality, transcription of DNA abnormality that 
may constitute a novel dimension to COVID-19 
treatment. In the pathogenesis of any disease, may it 
be Nija or Agantuja, asatmeyaindriyarthasam yoga, 
pargyaparadha and parinama, play a role of catalyst 
in disease pathogenesis
20
. These are epigenetic factors 
responsible for structural protein abnormality, 
genome code regulation, transcription of DNA 
abnormality susceptibility to disease
21
. Disturbance 




in epigenetic factors that interfere with viral 




The exact pathogenesis of COVID-19 is not  
known in most cases. In Ayurveda, the concept  
of Aam plays a significant role in the vitiation of 
Dosha (bio-humours) and disturbances in all the 
seven dhatus
23
. Weakened Dhatus and Dhatu Agnis 
are responsible for the pathophysiology of 
Agnimandya (hypo functioning of bio-fire) which in 
turn results in the formation of Aam. The statement 
―rogasarveapimandagnau (रोगासरे्वअपिमन्दाग्नौ)‖ is only 
to stress the importance of agni in any disease 
process. Ayurveda suggests that when the Dhatus are 
weakened, patients are vulnerable to infective 
disease
24
. In the present context of COVID-19, Aam 
may be considered as bio-toxins, in form of an 
abnormal protein, genetic code, genetic material, and 
inflammatory mediators, etc., released during the 
progression of the disease
25
. The treatment approach 
for the infectious disease includes balancing of 
Dosha, kindling of dhatvagni by Aampachana 
(eliminating toxins)
26
. In COVID-19, the events that 
follow after infection, impairs the functioning of 
Kayagni (digestive secretions and enzymes). The first 
dhatu, the Rasa (Chyle) is not properly formed and 
instead anna rasa retained in the amashaya (stomach 
& small intenstine) mixed up with Vatadi dosha. For 
Dhatu samyata (equilibrium of body tissues), 
restoration of Kayagni by Deepana pachana drugs; 
supportive drugs which helps in formation and 
nourishment of proper subsequent dhatus (rasa→ 
 
 
Fig. 1 — Photographs of different plants used for anti viral potential, anti inflammatory potential, activate immune cells potential, Nano 
minerals in COVID-19 




rakta→ mamsa→ meda→ asthi→ majja→ shukra); 
Rasayana drugs (rejuvenation therapy) for 
maintaining the essence of  life i.e.,  ojus  is  required.  
Deepana-pachana drugsstimulate agni, present in 
each and every cell of an organ, thus, helpful in 
bringing sama stage to nirama stage
27
. After Ama 
doshapachana, the vitiated doshas present in sakha 
(extremities) are brought to the Kostha (alimentary 
tract) and are removed from the body. According to 
Ayurveda, like any other disease, treatment principle 
for COVID-19 includes Samprapti vighatana 
(breaking the pathogenesis) through Nidana 
parivarjana (avoiding the factors responsible for the 
cause of the disease), Prakriti vighata (correcting the 
damaged or weaker tissue of the body to normal), 
Prakriti sthapana (correcting the respective site of 
 
 




Fig. 3 — Proposed Ayurveda herbs anti-inflammatory responses 




Dosha–dushya conglomeration), Dosapratyanika 
chikistha (Dosha specific treatment), Dhatusamya 
hikitsa (equilibrium of body tissues)
28
. 
Total 72 herbs and bhasmas with 55 therapeutic 
major molecular targets have been presented in  
Table 1-4. After systematic search from different 
databases, 16 herbs have been identified which block 
the coronavirus from entering into the host cells 
through two major targets (e.g., spike proteins, 
hesperidin); prevents the virus RNA synthesis and 
replication by five major targets (e.g., NSPs, PLpro, 
RdRp, 3CLpro, Helicase); inhibits viral structural 
proteins by one major targets (e.g., E protein or N 
protein); inhibits virulence factor by three major 
targets (e.g., NSP1, NSP3c, Orf7a); blocks host-
specific receptor or enzymes by two major targets 
(e.g., ACE2 protein, TMPRSS2); are described in 
Table 1.  
Thirty herbs that could inhibit inflammation by 
different pathways and thereby inhibit viral infection 
of cells are described in Table 2. Identified molecular 
therapeutic targets that control transcription of DNA, 
cytokine production and cell survival include three 
major targets e.g., NF-ΚB, TNF, IL-1β. MMP-9 is 
another target that breaks down the basement 
membrane surrounding blood vessels as well as 
Parenchymal extracellular matrix. Similarly, toxic 
metabolites are produced by one major target (e.g., 
CYP7A1); regulation of outer mitochondrial 
membrane permeability controlling the host cell life 
by two major targets (e.g., BCL2, Bfl-1/A1); having 
direct role in T cell differentiation by one major 
targets (e.g., JNK); activation of B-cell and T-cell 
proliferation by six major targets (e.g., IL-1, IL-4, IL-
6, IL-8, IL-12 IL-13); virus dissemination by one 
major targets (e.g., CASPASE-3); reduces 
demyelination in the CNS by one major targets (e.g., 
EGR-1); phosphorylation of transcriptional factors by 
one major targets (e.g., STAT1); have a role in a 
variety of immune activation responses by one major 
targets (e.g., Akt); inhibition of IL-6 cytokine 
expressed by alveoli cells in the lungs by one major 
target (e.g., JAK2) and reduction in endosomal entry 
by one major target (e.g., TYK) have been discussed 
in Table 2.  
Seventeen herbs that could affect 18 major 
molecular therapeutic targets which inhibit C3 or C5; 
increase Cytotoxic T-cells (CTLs) and Natural Killer 
(NK) cells; inhibit p38MAPK, STAT3, AhR, Th1, 
PAG, 5ht3, Nk1, IL-1β, and PLA2;, increase SOD, 
CAT, GPX, LPS, H2O2, MPO, and may be useful to 
activate the immune cells are presented in Table 3.  
Nine bhasmas have been identified and described 
in Table 4 that are supposed to work like nano metal 
particles based on their morphology. It helps in 
pharmacokinetics of the herbal drugs, optimize the 
immune response during vaccination, adjuvant to 
arrange antibodies in vivo and design vaccines against 
viral, bacterial and parasitic infections. Major five 
identified molecular targets which inhibits RIG-I, 
 
 
Fig. 4 — Proposed Ayurveda herbs Activating immune cells responses 
 




enhancing IL-8 production, inhibiting NF-κB 
signaling, blocks E protein-associated ion channel, 
modulating the glutathione redox system.  
The action of majority of the ingredients described 
in Table 1-4 like Swertia species, Vitis vinifera L., 
Commiphora mukul (Hook. ex Stocks), Curcuma 
longa L., Aloe vera (L.) Burm.f., Garcinia species etc. 
are mostly inhibiting the virus at the step of 
attachment and entry into the host cell, reduced the 
replication, inhibiting  virulence  factor  and  blocking  
Table 1 — Molecular targets of different plants used for anti-viral potential in COVID-19 
S. No Botanical name & family Ayurveda  
name 
Chemical constituent Molecular target Possible effect on 
COVID-19 
Ref. 
1. Ocimum basilicum L., 
Lamiaceae 
Van Tulsi Ursolic acid ↓Spike protein Inhibition of viral entry & 
attachment  
[29] 




↓Spike protein Inhibition of viral entry & 
attachment 
[30] 
3. Garcinia species,  
Clusiaceae 
Vrikshmla Mangostin ↓Spike protein Inhibition of viral entry & 
attachment 
[31] 
4. Swertia chirayita, 
Gentianaceae 
Chirayita Kouitchenside d,  
A-glucosyl hesperidin, 
kouitchenside 
















Inhibition of viral entry & 
attachment; Reduction of 
viral replication; 
Inhibition of virulence 
factor; Blocking of host 
specific receptor or 
enzymes 
[31] 
5. Phyllanthus emblica L., 
Phyllanthaceae 
Amalaki Phyllaemblicin g7 ↓Spike protein Inhibition of viral entry & 
attachment 
[31] 
6. Vitis vinifera L., 
Vitaceae 
Draksha Piceatannol ↓Spike protein Inhibition of viral entry & 
attachment 
[31] 









Blocking viral entry; 









↓PLpro protein Correction of virus 
replication; Antagonize 
the host‘s innate 
Immunity 
[33] 




↓3Clpro Prevents viral RNA 
synthesis & replication 
[31] 




10. Xylocarpa species,  
Fabaceae 













12. Vitex negundo L., 
Verbenaceae 
Nirgundi Vitexin ↓Nsp1 Inhibits virulence factor [31] 
13. Phyllanthus emblica L. 
Phyllanthaceae 
Amalaki Phyllaemblicin G7 ↓Ace2 protein Blocks host specific 






Reducing replication  [31] 
14. C. Aurantium, 
Rutaceae 
Jambira Neohesperidin and 
hesperidin 
↓Ace2 protein Blocks host specific 
receptor or enzymes 
[31] 
 





Table 2 — Molecular targets of different plants used for anti-inflammatory potential in COVID-19 








Supportive therapy effect on  
COVID-19 
Ref. 
1. Commiphora mukul 
(Hook. ex Stocks)., 
Burseraceae 




Controls transcription of DNA, 
cytokine production and cell survival; 
Inhibition of cell invasion through 
suppression of MMP-9; Regulates 
NF-kappaB-dependent genes 
[34] 
2. Brassica genus 
Brassicaceae 
Sarsapa Allylisothiocyanate ↓NF-κB Regulates glycerophospholipid 
metabolism  
[35] 




Saunf Anethole ↓NF-κB,  
↓JNKs pathway 
Blocks the inflammatory processes 
induced by LPS; Regulating pro-
inflammatory cytokine production, 
transcription factors. 
[36], [37] 
4. Coriandrum sativum L., 
Apiaceae 
Dhanyaka Anethole ↓NF-κB Activats host defence through 
innate immunity 
[38] 
↓JNKs pathway Antioxidant, Anti-Inflammatory, 
And Erk Signalling Inhibitory 
Properties 
[39] 




↓NF-Κb Blocks phosphorylation of ERK & 
JNK; Blocks translocation of NF-κB 
[40] 
↓IL-1, IL-4, IL-6, 
IL-8, IL-12 IL-13 
Increase the secretion of IL-8 by 
human primary dendritic cells. 
[41] 
6. Citrus limon L.  
Osbeck, Rutaceae  
Nimbu Citral, Citronyllyl 
acetate, Hesperidin 
Hesperetin 
↓NF-κB Reducing inflammatory targets 
including NF-κB, iNOS and  
COX-2, 
[42] 
7. Curcuma longa L., 
Zingiberaceae  











Through NF-κB pathways affected 
on HBV infections, Decreases 
phosphorylation of JNK, ERK1/2 
and p38 and COX-2 expression 
thereby nuclear factor κB (NF-κB) 
activation Enhances immunity 






8. Boswellia serrata  
Roxb. ex Colebr.,  
Burseraceae 
Sallaki Β-boswellic acid ↓NF-κB Inhibiting HSV-1 through 
modulation of NF-κB & 
 p38 MAPK pathway. 
[48] 




↓NF-κB Inhibiting ACE and xanthine 
oxidase  
[49] 
10. Citrullus colocynthis 
(L.) Schrad., 
Cucurbitaceae  
Indravaruni Caffeic acid 
Derivatives, 
Cucurbitacins 
↓NF-κB Improves lipid profile, antioxidant 
capacity & inflammation by altering 
gene expression 
[50] 
11. Glycyrrhiza glabra L., 
Fabaceae 
Yastimadhu Glycyrrhetic acid, 
isoliquiritigenin, 
liquiritigenin 
↓NF-κB Hepatoprotection against chronic 
liver inflammation through 
attenuating NF-κB activation  
[51] 
↓IL-1, IL-4,  
IL-6, IL-8,  
IL-12 IL-13 
Regulating the expression of 
inflammatory cytokines and  
CXCL-2 by blocking the  
IL-17/STAT3 pathway 
[52] 
12. Withania somnifera (L.) 
Dunal, Solanaceae 
Aswagandha Withaferin a, 
Withanolide 
↓NF-κB Inhibits cell adhesion through 
inhibition of ICAM-1 and VCAM-1 
expression; Blocks Akt; Down-





Bhallataka Anacardic acids ↓NF-κB Suppressed LPS activated nitric 
oxide production in mouse 
macrophage cell line 
[54] 
     (Contd.) 




host specific receptor or enzymes. Other drugs such as 
Brassica genus, Andrographis paniculata (Burm.f.) 
Nees, Phyllanthus emblica L. Foeniculum vulgare 
var. capillaceum Burnat, Gmelina arborea Roxb., 
Cyperus rotundus L. etc. facilitate it to perform its 
action by preventing the virus RNA synthesis and 
replication, blocking the phosphorylation of ERK and  
JNK and the translocation of NF-κB in macrophages. 
Few ingredients such as Tinospora cordifolia (Willd.) 
Miers, Phyllanthus emblica L., Vitis vinifera L,‎ 
Withania somnifera (L.) etc. act like cumulative 
beneficiary effect by activating the immune cells.  
Few help the main drug such as Swarna bhasma, 
Zingiber officinale Roscoe to release at the requisite 
Table 2 — Molecular targets of different plants used for anti-inflammatory potential in COVID-19 (Contd.) 








Supportive therapy effect on  
COVID-19 
Ref. 







↓IL-1, IL-4, IL-6, 
IL-8, IL-12 IL-13, 
↓Caspase-3 
pathway 
Suppression of the mRNA, Regulate 
inflammasome-mediated responses, 
Modulation of cAMP-dependent 
protein kinase, protein kinase C 
[55],  
[56] 
15. Zingiber officinale 
Roscoe.,  
Zingiberaceae 
Shunthi 10-gingirol ↓MMP-9 Suppression via MMP9 expression. [57] 
Zingerone ↓IL-1, IL-4, IL-6, 
IL-8, IL-12 IL-13 
 Protects lungs from severe damage 
due to inflammation. 
[58] 
16. Coriandrum sativum L., 
Apiaceae 
Dhanyak Anethole ↓JNKs pathway Antioxidant, Anti-Inflammatory, 
And Erk Signalling Inhibitory 
Properties 
[39] 
17. Vitis vinifera L., 
Vitaceae 
Draksha Resveratro,  
Oxalic acid 
↓JNKs pathway Regulation of cellular ROS through 
superoxide radical; Decreases 
intracellular glutathione levels. 
[59] 
↓NF-κB Reduces airway inflammation by 
inhibition of Syk/NF-κB pathway 
[60] 
Resveratrol, Oxalic acid, 
anthocyanins, flavan-3-
ols, flavonols, stilbenes 
and organic acids, 
proanthocyanidins 
↓IL-1, IL-4,  
IL-6, IL-8,  
IL-12 IL-13, 
↓EGR-1  
Inhibits inflammatory cytokines, 




18. Nigella sativa L., 
Ranunculaceae 
Kalaunji Oil ↓IL-1, IL-4,  
IL-6, IL-8,  
IL-12 IL-13 
Anti-inflammatory effects by 
reducing IL-4 and NO production, 
restoring the antioxidant status, 
Reducing lipid peroxidation 
[63] 
19. Phyllanthus amarus 
Schumach. & Thonn. 
Phyllanthaceae 
Bhuiamalaki Polyphenol  
compounds 
↓IL-1, IL-4,  
IL-6, IL-8,  
IL-12 IL-13 
Reduces proinflammatory cytokines 






Dalchini Type-A procyanidin 
polyphenols 
↓IL-1, IL-4,  
IL-6, IL-8,  
IL-12 IL-13 
Stabilizes mast cell and inhibits 
allergic markers i.e., histamine, IL-
4, and β-HEX in IgE-mediated 
manner. 
[65] 






Reducing inflammatory targets 
including NF-κB, iNOS and COX-2 
[42] 
22. Citrullus species, 
Cucurbitaceae  
Indravaruni Phytol ↓Akt Inhibits the growth of human T-cell [50] 
23. Piper longum L., 
Piperaceae 
Pippali Piperlongumine ↓Akt Activation may have a priming 
effect which can predispose lung 
tissue to pulmonary fibrosis. 
[66] 
↓JAK2 Regulating the Frequency of Th17 
and Regulatory T Cells 
[66] 
Aryl Hydrocarbon ↓IL-1, IL-4, IL-6, 
IL-8, IL-12 IL-13 
Regulation of T cells; increases T 
helper (Th) 1 and Th17 cells 
[67] 
 




site. Few ingredients such as Glycyrrhiza glabra L., 
Swarna bhasma etc act like adjuvant, and some  
others like bhasmas enhance the bioavailability  
of the drugs. Some drugs help while correcting the 
underlying pathogenesis, like Zingiber officinale 
Roscoe., Piper longum L. increasing agni, correcting 
the doshas and also acting as bioavailability 
enhancers etc.  
So, Ayurveda formulations can be developed by 
identifying the major targets either alone or by 
various permutation and combination that may fulfill 
the treatment for COVID-19. Their combination 
probably has little more advantage as it is the sum 
total of synergism, attenuation, antagonistic related to 
correction of status of dosha, dushya, agni and 
srotovikriti and finally attaining the Dhatusamyata 
(homostasis). Their combined action offers anti-viral, 
anti-inflammatory and immune cells activation 
activities usually aimed at the pathogenic picture of 
the disease COVID-19. 
Table 3 — Molecular targets of different plants used for activate immune cells potential in COVID-19 
S.no Botanical name & family Ayurveda 
name 
Chemical constituents Molecular target Supportive therapy effect 
on COVID-19 
Ref. 
1. Tinospora  cordifolia  
(Willd.) Miers, 
Menispermaceae 
Guduchi Syringin (TC-4) and 
 20ordial (TC-7)  
↓C3-convertase Enhances phagocytic 
activity; Increases in 
nitric oxide and ROS 
generation  
[68] 
2. Phyllanthus emblica L. Amalaki Ascorbic acid, Tocopherol 
Malanodialdehyde, 




Potent activity against 
influenza A virus 
[69] 
3. Piper nigrum L.,  
Piperaceae 
Maricha Piperine  ↓STAT3 pathway Blocks p-STAT3/p65 and 
Bcl-2 activation. 
[70] 
4. Piper longum L., 
Piperaceae 
Pippali Piperine ↓STAT3 pathway Blocks p-STAT3/p65 and 
Bcl-2 activation. 
[70] 
5. Glycyrrhiza glabra L., 
Fabaceae 
Yastimadhu Glycyrrhizin ↓AhR Potential toxicity-
alleviating agent 
[51] 
6. Aloe vera (L.) Burm.f., 
Asphodelaceae 
Kumari Anthraquinone glycosides ↓Th1,  
↓PAG 
Regulats Th1 and Th2 
cytokines.  
[71] 
7. Zingiber officinale 
Roscoe., Zingiberaceae 
Shunthi Gingerols, Shogaols ↓5ht3,  
↓IL-1β 
Possess a high binding 
affinity to sites 
[58] 
8. Boerhavia diffusa L, 
Nyctaginaceae 
Punarnava Alkaloid 
Boerhavia diffusa L. 
↓PLA2 Antioxidant activity. [72] 
9. Momordica charantia L, 
Cucurbitaceae 
Karela Alkaloids ↑ SOD Markers of oxidative 
stress which may be used 
as biomarkers of the aging 
process. 
[61] 




11. Syzygium cumini (L.), 
Myrtaceae 
Lavanga 
12. Hordeum vulgare L., 
Skeels, Poaceae 
Yava 
13. Gossypium herbaceum L, 
Malvaceae 
Karpasa 
14. Withania somnifera (L.) 
Dunal, Solanaceae 
Aswagandha Isopelletierine, Anaferine, 
Withanolides, Withaferins 
↑ SOD, ↑ CAT, 
↑GPX 
Antioxidant activity [53] 
15. Nigella sativa L., 
Ranunculaceae 
Kalunji Nigellidine ↑LPS Reduces severity of lung 
damage  
[73] 
16. Vitis vinifera L., ‎Vitaceae Draksha Resveratrol, -e-viniferin ↑ MPO  Protective against 
pulmonary fibrosis. 
[61] 
Alkaloids ↑ SOD Markers of oxidative 
stress which may be used 









Although no system of medicine has any evidence-
based treatment for COVID-19 so far, clinical 
interventions are being done worldwide based on drug 
repurposing strategy. This review reveals that there are 
ample evidences available, both in classical and 
contemporary science that shows the role of plant and 
mineral-based agents used in Ayurvedic medicine in 
suppressing multiple pathways involved in the genesis 
of COVID-19 through anti-viral, anti-inflammatory and 
immune cells activating molecular targets. Extensive 
research is needed on Ayurvedic formulations 
containing these therapeutic targets for establishment of 
their role in the treatment of COVID-19. 
 
Glossary 
Definition of Standard Ayurveda terms: 
Agni Represents the digestive power and 
metabolic rate of the body tissues. 
Agnimandya Represents the improper functioning of 
digestive power and metabolic rate of 
the body tissues resulting in low 
digestive power.  
Aam  Biotoxin released associated with food or 
other physiological entities to mean 
incomplete transformation or metabolism 
causing a harmful effect on health.  
Dhatu  One of the body tissues. Ayurveda 
describes 7 dhatus 
Dhatu agni The metabolic rate of the body tissues. 
Dosha Regulatory functional factors of the 
body. There are 3 doshas: Vata, pitta, 
and kapha. The three doshas are often 
called Tridoshas.  
Kapha The dosha representing structure.  
Pitta  The dosha representing transformation. 
Deepana 
drugs 
Therapeutic action of the drug which 
kindles the agni but cannot digest the 
Aam. Process by which the metabolic 
fire is enhanced  
Pachana 
drugs  
Drugs by which the undigested food, 
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